By Kris Herbst and Christian Moen
Contributing Editors

WASHINGTON - With the 535 members of Congress at home for a holiday recess that lasts almost through January, the opportunity would seem ripe for biotech companies to approach local lawmakers with their messages about disease cures, job creation and health care reform.